应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06078 海吉亚医疗
已收盘 09-03 16:08:21
10.230
-0.050
-0.49%
最高
10.390
最低
10.140
成交量
128.06万
今开
10.320
昨收
10.280
日振幅
2.43%
总市值
61.89亿
流通市值
61.89亿
总股本
6.05亿
成交额
1,311万
换手率
0.21%
流通股本
6.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
海吉亚医疗:9月3日回购48.86万股,耗资约499.86万港元
公告速递 · 17:52
海吉亚医疗:9月3日回购48.86万股,耗资约499.86万港元
海吉亚医疗8月股份变动月报:股本保持稳定
公告速递 · 16:51
海吉亚医疗8月股份变动月报:股本保持稳定
海吉亚医疗回购19.82万股股份,总额约203.06万港元
公告速递 · 09-02 19:24
海吉亚医疗回购19.82万股股份,总额约203.06万港元
海吉亚医疗(06078.HK)9月2日斥资203.06万港元回购19.82万股
智通财经 · 09-02 19:12
海吉亚医疗(06078.HK)9月2日斥资203.06万港元回购19.82万股
海吉亚医疗:9月1日回购2万股股份,涉资约20.50万港元
公告速递 · 09-01 18:16
海吉亚医疗:9月1日回购2万股股份,涉资约20.50万港元
海吉亚医疗(06078)9月1日斥资20.5万港元回购2万股
智通财经 · 09-01 18:15
海吉亚医疗(06078)9月1日斥资20.5万港元回购2万股
海吉亚医疗(06078)8月31日斥资185.46万港元回购18.1万股
智通财经 · 08-31
海吉亚医疗(06078)8月31日斥资185.46万港元回购18.1万股
海吉亚医疗2026年8月31日回购18.10万股,耗资约185.46万港元
公告速递 · 08-31
海吉亚医疗2026年8月31日回购18.10万股,耗资约185.46万港元
海吉亚医疗(06078)涨13.79% 中期净利润同比增长4.7%
金吾财讯 · 08-28
海吉亚医疗(06078)涨13.79% 中期净利润同比增长4.7%
港股异动 | 海吉亚医疗绩后涨超13%,上半年经调整净利环比增长38.1%
智通财经 · 08-28
港股异动 | 海吉亚医疗绩后涨超13%,上半年经调整净利环比增长38.1%
海吉亚医疗发布中期业绩:经调整净利润2.7亿元,环比增长38.1%
格隆汇 · 08-27
海吉亚医疗发布中期业绩:经调整净利润2.7亿元,环比增长38.1%
海吉亚医疗(06078)发布2026年中期业绩 净利润同比增4.7%至2.6亿元
公告速递 · 08-27
海吉亚医疗(06078)发布2026年中期业绩 净利润同比增4.7%至2.6亿元
海吉亚医疗2026年上半年营收19.61亿元,经调整净利润2.66亿元
公告速递 · 08-27
海吉亚医疗2026年上半年营收19.61亿元,经调整净利润2.66亿元
海吉亚医疗(06078.HK)发布中期业绩 净利润2.57亿元 同比增加4.7%
智通财经 · 08-27
海吉亚医疗(06078.HK)发布中期业绩 净利润2.57亿元 同比增加4.7%
海吉亚医疗:决议不宣派截至2026年6月30日止六个月任何股息
美股速递 · 08-27
海吉亚医疗:决议不宣派截至2026年6月30日止六个月任何股息
【券商聚焦】中信建投:肿瘤mRNA疫苗开创肿瘤治疗新范式,国内企业加速追赶
金吾财讯 · 08-24
【券商聚焦】中信建投:肿瘤mRNA疫苗开创肿瘤治疗新范式,国内企业加速追赶
海吉亚医疗(06078)定于8月27日审议2026年中期业绩及派息计划
公告速递 · 08-12
海吉亚医疗(06078)定于8月27日审议2026年中期业绩及派息计划
海吉亚医疗更新7月股份变动月报表,总发行股数保持618,499,000股
公告速递 · 08-06
海吉亚医疗更新7月股份变动月报表,总发行股数保持618,499,000股
【券商聚焦】交银国际:下半年医药板块有望迎来修复 但内部分化或持续加大
金吾财讯 · 07-28
【券商聚焦】交银国际:下半年医药板块有望迎来修复 但内部分化或持续加大
海吉亚医疗7月27日回购19.94万股,耗资约199.82万港元
公告速递 · 07-27
海吉亚医疗7月27日回购19.94万股,耗资约199.82万港元
加载更多
公司概况
公司名称:
海吉亚医疗
所属市场:
SEHK
上市日期:
--
主营业务:
海吉亚医疗控股有限公司是一家主要提供医疗服务的投资控股公司。该公司通过两个业务部门开展业务。医院业务分部从事提供肿瘤一站式综合诊疗服务,围绕肿瘤核心业务开展多学科医疗服务,包括提供医疗放疗、化疗、手术、靶向在内的多重肿瘤医疗服务,逐步覆盖癌症诊断、治疗与康复等各阶段。其它业务分部主要从事其他业务。该公司主要在国内市场经营其业务。
发行价格:
--
{"stockData":{"symbol":"06078","market":"HK","secType":"STK","nameCN":"海吉亚医疗","latestPrice":10.23,"timestamp":1788422901004,"preClose":10.28,"halted":0,"volume":1280600,"delay":0,"changeRate":-0.004863813229571881,"floatShares":605000000,"shares":605000000,"eps":0.3106242583194806,"marketStatus":"已收盘","change":-0.05,"latestTime":"09-03 16:08:21","open":10.32,"high":10.39,"low":10.14,"amount":13108920,"amplitude":0.024319,"askPrice":10.24,"askSize":600,"bidPrice":10.23,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.3314408501082082,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":5,"adr":0,"listingDate":1593360000000,"exchange":"SEHK","adjPreClose":10.28,"openAndCloseTimeList":[[1788399000000,1788408000000],[1788411600000,1788422400000]],"volumeRatio":0.211847,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06078","defaultTab":"news","newsList":[{"id":"1187981496","title":"海吉亚医疗:9月3日回购48.86万股,耗资约499.86万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187981496","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187981496?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:52","pubTimestamp":1788429136,"startTime":"0","endTime":"0","summary":"海吉亚医疗控股有限公司于2026年9月3日发布翌日披露报表,宣布当日通过香港联合交易所场内回购公司普通股48.86万股,约占回购前已发行股本的0.0807%。每股回购价格介乎港币10.15元至10.25元,合计耗资约499.86万港元。公司在公告中强调,本次股份回购已获得董事会正式授权并符合香港联合交易所有关上市规则及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海吉亚医疗:9月3日回购48.86万股,耗资约499.86万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158018459","title":"海吉亚医疗8月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1158018459","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158018459?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:51","pubTimestamp":1788425512,"startTime":"0","endTime":"0","summary":"海吉亚医疗控股有限公司于2026年9月3日发布截至2026年8月31日的股份变动月报。报告期内,公司法定股本维持5,000,000,000股普通股,面值均为每股0.00001美元,总注册股本对应50,000美元,较上月没有变化。购回与库存股方面,2026年6月26日公司购回了181,000股股份,并将其作为库存股份持有,截至2026年8月31日,尚未注销。该部分购回导致已发行股份数量减少,相对应增加了相同数量的库存股份,未影响公司股份总数。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198841687","title":"海吉亚医疗回购19.82万股股份,总额约203.06万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198841687","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198841687?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:24","pubTimestamp":1788348261,"startTime":"0","endTime":"0","summary":"海吉亚医疗控股有限公司于2026年9月2日公告,显示公司当日于香港联交所场内回购普通股19.82万股,约占该次回购前已发行股份的0.0327%。回购价格区间为每股10.22港元至10.25港元,合共支付约203.06万港元。回购后,公司已发行股本总数维持618,499,000股,其中流通股为605,253,000股,库存股增至13,246,000股。公司指出,本次股份回购依据2026年6月26日通过的购回授权进行,授权总额为60,774,100股,截至目前已在香港联交所回购股份合共2,488,000股,占授权通过时已发行股本的约0.4094%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海吉亚医疗回购19.82万股股份,总额约203.06万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008815","title":"海吉亚医疗(06078.HK)9月2日斥资203.06万港元回购19.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664008815?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:12","pubTimestamp":1788347565,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0737861772.HKD","BK1209","LU0329678337.USD","LU2488822045.USD","LU0329678170.USD","06078","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128550545","title":"海吉亚医疗:9月1日回购2万股股份,涉资约20.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128550545","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128550545?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:16","pubTimestamp":1788257767,"startTime":"0","endTime":"0","summary":"海吉亚医疗控股有限公司于2026年9月1日发布翌日披露报表,宣布当日通过香港联交所场内回购普通股2万股,每股回购价为10.25港元,总金额约20.50万港元。公告显示,此次回购股份占前一交易日公司已发行股份约0.0033%。本次回购完成后,公司已发行股份由6.054712亿股降至6.054512亿股,库藏股数量由1302.78万股增至1304.78万股,已发行股份总数维持6.18499亿股不变。公司同时确认已遵守相关上市规则及法律规定。本公告由执行董事任爱签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海吉亚医疗:9月1日回购2万股股份,涉资约20.50万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664585968","title":"海吉亚医疗(06078)9月1日斥资20.5万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664585968","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664585968?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:15","pubTimestamp":1788257714,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海吉亚医疗(06078)发布公告,于2026年9月1日,该公司斥资20.5万港元回购2万股股份,每股回购价10.25港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0737861772.HKD","BK1583","LU2488822045.USD","LU0329678170.USD","LU0329678337.USD","06078","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663717810","title":"海吉亚医疗(06078)8月31日斥资185.46万港元回购18.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663717810","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663717810?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:04","pubTimestamp":1788170643,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海吉亚医疗(06078)发布公告,该公司于2026年8月31日斥资185.46万港元回购18.1万股股份,每股回购价格为10.15-10.3港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1209","LU2488822045.USD","BK1583","LU0737861772.HKD","06078","LU0329678337.USD","LU0329678170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152357483","title":"海吉亚医疗2026年8月31日回购18.10万股,耗资约185.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152357483","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152357483?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:01","pubTimestamp":1788170506,"startTime":"0","endTime":"0","summary":"海吉亚医疗控股有限公司于2026年8月31日公告显示,公司在香港联交所场内回购18.10万股普通股,占回购前已发行股本约0.0299%。此次回购每股价格介乎10.15港元至10.30港元,合计耗资约185.46万港元。回购完成后,公司已发行股本由原先的605,652,200股减少至605,471,200股,库藏股数量相应升至13,027,800股。根据该公告,对于回购后30日内的新股发行或库藏股再出售,公司亦严格遵循香港联交所上市规则的相关暂止期至2026年9月30日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海吉亚医疗2026年8月31日回购18.10万股,耗资约185.46万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703092","title":"海吉亚医疗(06078)涨13.79% 中期净利润同比增长4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703092","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703092?lang=zh_cn&edition=full","pubTime":"2026-08-28 09:46","pubTimestamp":1787881594,"startTime":"0","endTime":"0","summary":"金吾财讯 | 海吉亚医疗(06078)早盘股价扬升,最新涨13.79%,报10.7港元,成交额4895万港元。消息面上,海吉亚医疗公布截至2026年6月30日止六个月中期业绩。期内收入为19.61亿元人民币,较2025年同期减少1.4%;净利润为2.574亿元人民币,同比增长4.7%;非国际财务报告准则经调整净利润为2.665亿元人民币,同比增长1.5%。毛利率为27.4%,较2025年同期提升0.8个百分点。经营活动所得现金净额为4.587亿元人民币,同比增长0.7%;自由现金流为2.963亿元人民币,同比增长38.5%;净现比为178.2%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989844","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662793037","title":"港股异动 | 海吉亚医疗绩后涨超13%,上半年经调整净利环比增长38.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662793037","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662793037?lang=zh_cn&edition=full","pubTime":"2026-08-28 09:41","pubTimestamp":1787881298,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海吉亚医疗涨超12%,截至发稿,涨12.41%,报10.6港元,成交额3317.8万港元。消息面上,海吉亚医疗发布2026年中期业绩,上半年收入19.6亿,同比下降1.4%;净利润2.6亿,同比增长4.7%;经调整净利润2.7亿,同比增长1.5%,环比增长38.1%。毛利率27.4%,经调整净利率13.6%,均同比企稳回升。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487707.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU0737861772.HKD","06078","KCAI","LU0329678170.USD","LU2488822045.USD","VXUS","BK1209","BK4588","LU0329678337.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709110","title":"海吉亚医疗发布中期业绩:经调整净利润2.7亿元,环比增长38.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709110","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709110?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:04","pubTimestamp":1787828644,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0737861772.HKD","BK1583","LU2488822045.USD","06078","LU0329678337.USD","BK1209","LU0329678170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176603403","title":"海吉亚医疗(06078)发布2026年中期业绩 净利润同比增4.7%至2.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176603403","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176603403?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:23","pubTimestamp":1787826216,"startTime":"0","endTime":"0","summary":"香港,2026年8月27日,海吉亚医疗控股有限公司(股票代码:06078,以下简称“海吉亚医疗”)披露截至2026年6月30日止六个月(“报告期”)未经审核的主要经营及财务数据。公司将于2026年8月28日08时30分(香港时间)举行电话业绩说明会,介绍财务表现及业务进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116946981","title":"海吉亚医疗2026年上半年营收19.61亿元,经调整净利润2.66亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116946981","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116946981?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:06","pubTimestamp":1787825163,"startTime":"0","endTime":"0","summary":"2026年上半年,海吉亚医疗录得营收19.61亿元,同比下降1.4%;经调整净利润为2.66亿元,同比增长1.5%。报告期内,毛利率提升至27.4%,较上年同期增加0.8个百分点。经营活动现金流净额达4.59亿元,同比增长0.7%;自由现金流为2.96亿元,同比增长38.5%。销售开支为0.32亿元,占营收比重1.6%;行政开支为2.10亿元,占营收比重10.7%,较上年同期下降0.3个百分点。有息负债为22.56亿元,较上年末减少7.4%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"海吉亚医疗2026年上半年营收19.61亿元,经调整净利润2.66亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087627","title":"海吉亚医疗(06078.HK)发布中期业绩 净利润2.57亿元 同比增加4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087627?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:03","pubTimestamp":1787825031,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1209","LU2488822045.USD","LU0329678170.USD","06078","LU0737861772.HKD","LU0329678337.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101707835","title":"海吉亚医疗:决议不宣派截至2026年6月30日止六个月任何股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1101707835","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101707835?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:57","pubTimestamp":1787824628,"startTime":"0","endTime":"0","summary":"海吉亚医疗(HYGEIA HEALTH)——已决议不推荐宣派截至2026年6月30日止六个月期间的任何股息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0737861772.HKD","BK1583","LU2488822045.USD","06078","LU0329678337.USD","BK1209","LU0329678170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244441","title":"【券商聚焦】中信建投:肿瘤mRNA疫苗开创肿瘤治疗新范式,国内企业加速追赶","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244441","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661244441?lang=zh_cn&edition=full","pubTime":"2026-08-24 09:19","pubTimestamp":1787534349,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,随着Moderna个性化肿瘤mRNA疫苗临床III期取得积极结果,mRNA肿瘤疫苗正朝着商业化阶段迈进,市场空间有望逐步打开。mRNA肿瘤疫苗与ICIs联用有望开创肿瘤治疗的新范式。分类来看,个性化肿瘤疫苗具有潜在更优的治疗效果,虽然生产成本较高,但也有更大的定价空间,而通用型疫苗凭规模化生产和较低成本,有望覆盖更广泛的患者群体。AI有望赋能多个环节,加速mRNA肿瘤疫苗的迭代升级。目前国内肿瘤mRNA疫苗研发正加速追赶,未来有望实现差异化突破,相关企业及产业链公司有望受益。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989097","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601066","BK0276","MRNY","CANC","KCE","MRNX","LU0329678170.USD","LU0329678337.USD","LU0737861772.HKD","BK1209","06078","LU2488822045.USD","BK1583","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149441179","title":"海吉亚医疗(06078)定于8月27日审议2026年中期业绩及派息计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1149441179","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149441179?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524359,"startTime":"0","endTime":"0","summary":"海吉亚医疗控股有限公司(06078)8月12日公告称,公司董事会将于2026年8月27日(星期四)召开会议,审议及批准集团截至2026年6月30日止六个月的中期业绩,并考虑建议派发中期股息(如有)。\n公告显示,出席会议的董事包括主席兼执行董事朱义文,以及执行董事任爱、程欢欢、张文山、姜蕙和独立非执行董事叶长青、赵淳、张国忠。\n公司将在董事会会议后发布2026年中期业绩报告及派息决定(如有)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104963143","title":"海吉亚医疗更新7月股份变动月报表,总发行股数保持618,499,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1104963143","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104963143?lang=zh_cn&edition=full","pubTime":"2026-08-06 18:35","pubTimestamp":1786012548,"startTime":"0","endTime":"0","summary":"2026年8月6日,海吉亚医疗控股有限公司公布截至2026年7月31日的证券变动月报表。公司注册于开曼群岛,法定股本总额维持50,000美元,对应5,000,000,000股普通股,每股面值0.00001美元。报告期内,公司已发行股本由607,741,000股减少至605,652,200股,库存股由10,758,000股增至12,846,800股,合计总发行股数继续保持在618,499,000股。根据公告,7月在2026年7月7日、9日、13日、14日、17日、20日、21日、22日、23日、24日及27日,公司共回购2,088,800股普通股,并将其列为库存股,尚未注销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654458022","title":"【券商聚焦】交银国际:下半年医药板块有望迎来修复 但内部分化或持续加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2654458022","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654458022?lang=zh_cn&edition=full","pubTime":"2026-07-28 10:01","pubTimestamp":1785204072,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,近一个月恒生医疗保健指数涨17.4%,跑赢大市。其中,生物药、CXO及处方药板块表现较优于其他板块。机构持仓方面,2026年年中以来,内资持仓延续提升态势,而外资则略有降低。该机构指,中报季临近,7月以来多家公司业绩预告陆续发布,CXO板块表现亮眼,业绩和订单延续高增长态势。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986903","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU2039709279.SGD","06990","159938","LU2476274308.USD","KURE","01548","01952","KCE","LU0588546209.SGD","03759","01801","09939","06996","LU1880383366.USD","LU2328871848.SGD","LU1813983027.USD","LU0634319403.HKD","LU0348783233.USD","LU0572944931.SGD","02268","LU1720050803.USD","BK1521","03329","LU2399975544.HKD","LU0856984785.SGD","01093","09926","HK0000320223.HKD","LU2097828714.EUR","09996","02162","BK1219","03692","BK1587","LU0417516571.SGD","02596","00013","09966","06821","LU0196878994.USD","02096","06160","02269","01177","01951","02273","06078","01530","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158990033","title":"海吉亚医疗7月27日回购19.94万股,耗资约199.82万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158990033","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158990033?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:46","pubTimestamp":1785149190,"startTime":"0","endTime":"0","summary":"海吉亚医疗于2026年7月27日发布翌日披露报表,公告公司于当日通过香港联交所场内回购普通股19.94万股,占回购前公司已发行股份总数的0.0329%,每股回购价格在9.95港元至10.05港元之间,合计耗资约199.82万港元。根据此前于2026年6月26日获得股东会通过的回购授权,海吉亚医疗可回购股份共60,774,100股,截至公告日期,已累计购回2,088,800股,占回购授权通过当日已发行股份总数的0.3437%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海吉亚医疗7月27日回购19.94万股,耗资约199.82万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hygeia-group.com","stockEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":0.0342},{"period":"3month","weight":0.0959},{"period":"6month","weight":-0.1931},{"period":"1year","weight":-0.3142},{"period":"ytd","weight":-0.1723}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"海吉亚医疗控股有限公司是一家主要提供医疗服务的投资控股公司。该公司通过两个业务部门开展业务。医院业务分部从事提供肿瘤一站式综合诊疗服务,围绕肿瘤核心业务开展多学科医疗服务,包括提供医疗放疗、化疗、手术、靶向在内的多重肿瘤医疗服务,逐步覆盖癌症诊断、治疗与康复等各阶段。其它业务分部主要从事其他业务。该公司主要在国内市场经营其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.051247},{"month":2,"riseRate":0.666667,"avgChangeRate":0.072177},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.074596},{"month":4,"riseRate":1,"avgChangeRate":0.075042},{"month":5,"riseRate":0.666667,"avgChangeRate":0.055792},{"month":6,"riseRate":0.333333,"avgChangeRate":0.010845},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.005309},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.053024},{"month":9,"riseRate":0.571429,"avgChangeRate":0.059017},{"month":10,"riseRate":0.5,"avgChangeRate":-0.047719},{"month":11,"riseRate":0.5,"avgChangeRate":0.039744},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.074768}],"exchange":"SEHK","name":"海吉亚医疗","nameEN":"HYGEIA HEALTH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海吉亚医疗(06078)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海吉亚医疗(06078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海吉亚医疗,06078,海吉亚医疗股票,海吉亚医疗股票老虎,海吉亚医疗股票老虎国际,海吉亚医疗行情,海吉亚医疗股票行情,海吉亚医疗股价,海吉亚医疗股市,海吉亚医疗股票价格,海吉亚医疗股票交易,海吉亚医疗股票购买,海吉亚医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海吉亚医疗(06078)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海吉亚医疗(06078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}